What is the share price of Brawn Biotech Ltd (BRAWN) today?
The share price of BRAWN as on 30th April 2025 is ₹18.14. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Brawn Biotech Ltd (BRAWN) share?
The past returns of Brawn Biotech Ltd (BRAWN) share are- Past 1 week: 6.71%
- Past 1 month: 11.70%
- Past 3 months: 11.91%
- Past 6 months: -12.54%
- Past 1 year: -23.30%
- Past 3 years: -0.06%
- Past 5 years: -41.48%
What are the peers or stocks similar to Brawn Biotech Ltd (BRAWN)?
The peers or stocks similar to Brawn Biotech Ltd (BRAWN) include:What is the market cap of Brawn Biotech Ltd (BRAWN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brawn Biotech Ltd (BRAWN) is ₹5.44 Cr as of 30th April 2025.What is the 52 week high and low of Brawn Biotech Ltd (BRAWN) share?
The 52-week high of Brawn Biotech Ltd (BRAWN) is ₹27.82 and the 52-week low is ₹15.46.What is the PE and PB ratio of Brawn Biotech Ltd (BRAWN) stock?
The P/E (price-to-earnings) ratio of Brawn Biotech Ltd (BRAWN) is -4.35. The P/B (price-to-book) ratio is 1.08.Which sector does Brawn Biotech Ltd (BRAWN) belong to?
Brawn Biotech Ltd (BRAWN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Brawn Biotech Ltd (BRAWN) shares?
You can directly buy Brawn Biotech Ltd (BRAWN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Brawn Biotech Ltd
BRAWN Share Price
BRAWN Share Price Chart
How to use scorecard? Learn more
BRAWN Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-3.30 | 1.08 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.81 | 6.38 | 0.53% |
BRAWN Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
BRAWN Company Profile
Brawn Biotech Limited is an integrated healthcare company in India, offering a wide range of pharmaceutical products including antibacterials, cardiovasculars, antifungals, and more.
BRAWN Similar Stocks (Peers)
Compare with peersBRAWN Forecasts
Price
Revenue
Earnings
BRAWN Share Price Forecast
BRAWN Company Revenue Forecast
BRAWN Stock EPS (Earnings Per Share) Forecast
BRAWN
Income
Balance Sheet
Cash Flow
BRAWN Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 46.89 | 61.17 | 55.87 | 65.92 | 49.79 | 35.29 | 8.62 | 22.24 | 16.58 | 14.74 | ||||||||||
Raw Materials | 39.99 | 52.07 | 48.82 | 58.49 | 42.15 | 29.89 | 11.05 | 19.24 | 15.59 | 16.27 | ||||||||||
Power & Fuel Cost | 0.01 | 0.01 | 0.03 | 0.05 | 0.05 | 0.04 | 0.02 | 0.06 | 0.08 | |||||||||||
Employee Cost | 1.86 | 1.98 | 2.98 | 3.02 | 3.08 | 2.36 | 1.80 | 1.40 | 1.40 | |||||||||||
Selling & Administrative Expenses | 2.92 | 2.16 | 1.74 | 2.29 | 2.07 | 1.50 | 1.81 | 1.55 | 1.76 | |||||||||||
Operating & Other expenses | 0.67 | 3.09 | 0.25 | 0.16 | 1.53 | 1.78 | -4.06 | 0.28 | -0.86 | |||||||||||
EBITDA | 1.44 | 1.86 | 2.05 | 1.91 | 0.91 | -0.28 | -2.00 | -0.29 | -1.39 | -1.53 | ||||||||||
Depreciation/Amortization | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.11 | 0.10 | 0.12 | ||||||||||
PBIT | 1.41 | 1.83 | 2.02 | 1.88 | 0.88 | -0.31 | -2.05 | -0.40 | -1.49 | -1.65 | ||||||||||
Interest & Other Items | 0.11 | 0.07 | 0.06 | 0.07 | 0.05 | 0.04 | 0.06 | 0.01 | 0.06 | — | ||||||||||
PBT | 1.30 | 1.76 | 1.96 | 1.81 | 0.83 | -0.35 | -2.11 | -0.41 | -1.55 | -1.65 | ||||||||||
Taxes & Other Items | 0.36 | 0.36 | 0.68 | 0.48 | 0.23 | 0.20 | -0.47 | 0.45 | -0.30 | — | ||||||||||
Net Income | 0.94 | 1.40 | 1.28 | 1.33 | 0.60 | -0.55 | -1.64 | -0.86 | -1.25 | -1.65 | ||||||||||
EPS | 3.13 | 4.67 | 4.27 | 4.43 | 2.00 | -1.83 | -5.47 | -2.87 | -4.17 | -5.50 | ||||||||||
DPS | 1.00 | 1.50 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.32 | 0.32 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BRAWN Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFBRAWN Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Brawn Biotech Ltd | -4.35 | 1.08 | — |
Sun Pharmaceutical Industries Ltd | 45.24 | 6.46 | 0.75% |
Cipla Ltd | 30.21 | 4.65 | 0.84% |
Torrent Pharmaceuticals Ltd | 67.89 | 16.40 | 0.84% |
BRAWN Stock Price Comparison
Compare BRAWN with any stock or ETFBRAWN Shareholdings
BRAWN Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
BRAWN Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
BRAWN Shareholding Pattern
BRAWN Shareholding History
smallcases containing BRAWN stock
Looks like this stock is not in any smallcase yet.
BRAWN Events
BRAWN Dividend Trend
BRAWN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
BRAWN Upcoming Dividends
No upcoming dividends are available
BRAWN Past Dividends
Cash Dividend
Ex DateEx DateSep 12, 2018
Dividend/Share
₹1.00
Ex DateEx Date
Sep 12, 2018
Cash Dividend
Ex DateEx DateSep 14, 2017
Dividend/Share
₹1.50
Ex DateEx Date
Sep 14, 2017
BRAWN Stock News & Opinions
Net Loss of Brawn Biotech reported to Rs 0.43 crore in the quarter ended December 2024 as against net loss of Rs 0.61 crore during the previous quarter ended December 2023. Sales rose 35.21% to Rs 3.84 crore in the quarter ended December 2024 as against Rs 2.84 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.842.84 35 OPM %-10.42-20.42 - PBDT-0.40-0.58 31 PBT-0.43-0.61 30 NP-0.43-0.61 30 Powered by Capital Market - Live
Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quarter ended September 2023. Sales rose 13.01% to Rs 3.30 crore in the quarter ended September 2024 as against Rs 2.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.302.92 13 OPM %-9.39-13.36 - PBDT-0.31-0.39 21 PBT-0.34-0.42 19 NP-0.34-0.42 19 Powered by Capital Market - Live
Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net loss of Rs 0.17 crore during the previous quarter ended June 2023. Sales declined 44.31% to Rs 4.06 crore in the quarter ended June 2024 as against Rs 7.29 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.067.29 -44 OPM %-12.32-2.06 - PBDT-0.50-0.15 -233 PBT-0.53-0.17 -212 NP-0.53-0.17 -212 Powered by Capital Market - Live
Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -24.12%, vs industry avg of 9.04%
Over the last 5 years, market share decreased from 0.03% to 0%